NEWS

30 January 2013

EVI 15th Anniversary Symposium

EVI is pleased to announce a symposium on global health issues under the Patronage of the Minister for Science, Research and Art, Baden Württemberg, that will take place in Heidelberg, 26 February 2013 on the occasion of EVI´s 15th Anniversary. The agenda is available.

16 January 2013

MVVC Annual Meeting in Dakar

The Malaria Vectored Vaccine Consortium (MVVC) is funded by the European and Developing Countries' Clinical Trials Partnership (EDCTP), which is developing much needed  malaria vaccines.

15 January 2013

Short course: Epidemiological Evaluation of Vaccines: Efficacy, Safety and Policy (LSHTM)

The overall aim of this short course is to provide an understanding of the methods used in the evaluation of vaccines, from early human trials through to assessment of population impact and policy. 

19 December 2012

Two EDCTP grants awarded to EVI

1. MVVC 2 (Malaria Vectored Vaccines Consortium 2): Field Trials of a New Combination Malaria Vaccine in West African Adults and Children

2. P27A CTb (P27A Phase Ib Clinical Trial)

Please open news item for details

21 November 2012

EVI Press Release on the interim results of the recent RTS, S phase III efficacy trial

The European Vaccine Initiative urges continued and sustainable malaria vaccine development efforts and funding.

Press release

19 November 2012

TRANSVAC Training Courses - Cut-off date for applications: 12 January 2013

TRANSVAC is now launching the second Training course "Practical approaches to vaccine development".

08 November 2012

Five additional groups joined TRANSVAC and provide their services to users on a free and paid basis

In addition to the initial groups, TRANSVAC transnational access platform has integrated five additional groups, who provide their services to users on a free and paid basis. Read the TRANSVAC Press release about the new services.

26 October 2012

Very positive feedback for the TRANSVAC Training Course 2012 on "Practical approaches to vaccine development"

The first TRANSVAC training course on “Practical approaches to vaccine development” was held on 3-6 September 2012 at the Vaccine Formulation Laboratory (VFL) training center, University of Lausanne, Switzerland. Read the Post-training advert to learn more about the course agenda and the feedbacks from the participants.

01 October 2012

EVI 2012 Rendez-Vous, 6 December 2012

EVI extends thanks to all speakers, chairs and other participants for making the 2012 RdV a resounding success.

Please visit the Rendez-Vous page for:

Meeting report, agenda, list of participants and photos

28 September 2012

Report of second TRANSVAC Stakeholder workshop is now available

Held in Brussels on the 13th June 2012 , the Second TRANSVAC Stakeholder Workshop focused on two main topics:
I) What are regulatory challenges in vaccine development and how can we solve them together?
II) How can the 'One Health' concept help us during the quest for new and better vaccines?